[A] weak yen and rising interest rates have continued even further, with the primary cause being the increase in crude oil prices due to U.S. attacks on Iran.
Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.